Loading ...

Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

(

)

ITN Protocol #:

ITN013ST

Branded Name:

ClinicalTrials.Gov ID:

NCT00078559

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Complete

Summary:

The Use of Campath-1H, Tacrolimus, and Sirolimus Followed by Sirolimus Withdrawal in Renal Transplant Patients

Clinical Operations Manager

ITN Biologist

NIAID Project Manager

Rho Data Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Michele DesMaraismdesmarais@immunetolerance.org

Work: 

415-420-4250

Protocol Chair

Kristina Harris, PhDkharris@immunetolerance.org

Work: 

240-235-6154

Protocol Chair

Helena Diopdioph@niaid.nih.gov

Work: 

301-402-7257

Protocol Chair

Elizabeth Mayelizabeth_may@rhoworld.com

Work: 

919-595-6345

Protocol Chair

David Ikle, PhDDavid_Ikle@rhoworld.com

Work: 

919-595-6378

Protocol Chair

Carol RobinsonCarol.Robinson@ppdi.com

Work: 

434-295-0520